Assessing healthcare status and challenges in border regions: insights from Tak and Mae Hong Son provinces, Thailand – a mixed-method approach.

Publication date: Jul 05, 2025

Thailand’s Tak and Mae Hong Son (MHS) provinces, bordering Myanmar, are critical entry points for individuals seeking employment or healthcare. The COVID-19 pandemic and Myanmar’s political instability have significantly impacted the health and performance of border-area health systems. This analysis examines the current state of the health sector, border health challenges resulting from cross-border movement, and identifies key gaps through data from health organizations and interviews in Tak and MHS provinces. A mixed-method situational analysis was conducted, incorporating documentary analysis (quantitative health facility data, national reports, and online survey data) and key informant interviews in five districts: Umpang, Mae Ramat, and Tha Song Yang (TSY) in Tak province, and Mueang and Pang Mapha in MHS province. A purposive sample of 42 participants, including community health workers and service providers, was interviewed on-site. Thematic analysis was used to interpret patterns within the interview data. The non-Thai population makes up 20-30% of Tak and MHS provinces, with varying compositions across districts. Umpang has a high number of hill tribe ethnic minorities, TSY sees many cross-border patients, Mae Ramat has a large migrant worker population, and Mueang and Pang Mapha host people displaced by conflict. Between 2020 and 2023, malaria cases surged in Umpang and TSY, while TB incidence spiked in TSY, with non-Thais being 2-3 times more affected than Thais. This puts significant financial pressure on local health systems, as many non-Thais, including cross-border Myanmar nationals, lack health insurance, limiting access to subsidized healthcare. Additionally, resource shortages and insufficient healthcare staff further strain border health management. To bridge these gaps, many non-governmental organizations actively work to support healthcare services in Tak province. Addressing these challenges requires coordinated efforts to ensure equitable healthcare access and sustainable resource allocation in border regions. The study highlights significant health challenges in Tak and MHS provinces, particularly in districts with high non-Thai populations. Diseases like malaria and TB are more prevalent in these areas, straining local health systems. Financial and staffing challenges underscore the need for proactive government support and cross-sector collaboration to improve health equity in these culturally diverse border communities.

Open Access PDF

Concepts Keywords
Healthcare Border health
Interviews COVID-19
Malaria Female
Thailand Health facilities
Health service
Health Services Accessibility
Humans
Male
Myanmar
Population movement
SARS-CoV-2
Thailand

Semantics

Type Source Name
disease MESH COVID-19 pandemic
disease IDO facility
drug DRUGBANK Tacrine
disease IDO site
disease IDO host
disease MESH malaria
pathway KEGG Malaria
drug DRUGBANK Etoperidone
pathway REACTOME Reproduction
drug DRUGBANK Trestolone
drug DRUGBANK Tretamine
drug DRUGBANK Huperzine B
drug DRUGBANK Gold
drug DRUGBANK Coenzyme M
disease MESH infectious diseases
disease MESH elephantiasis
disease IDO process
drug DRUGBANK Cyclic Adenosine Monophosphate
disease MESH emergency
drug DRUGBANK Water
drug DRUGBANK Uridine monophosphate
drug DRUGBANK Nonoxynol-9
drug DRUGBANK Ethionamide
disease IDO country
disease MESH unemployment
drug DRUGBANK Stavudine
disease MESH retirements
drug DRUGBANK Serine
disease IDO role
drug DRUGBANK Ilex paraguariensis leaf
disease MESH tuberculosis
pathway KEGG Tuberculosis
drug DRUGBANK Medical air
drug DRUGBANK Troleandomycin
disease MESH AIDS
disease MESH dengue fever
drug DRUGBANK Methacholine
disease MESH Malnutrition
disease MESH ARC
drug DRUGBANK 3 7 11 15-Tetramethyl-Hexadecan-1-Ol
drug DRUGBANK Azelaic acid
drug DRUGBANK Polyethylene glycol
drug DRUGBANK Indoleacetic acid
disease MESH respiratory infections
disease MESH morbidity
disease MESH vaccine preventable diseases
disease MESH vector borne diseases
disease IDO blood
disease MESH privacy
disease IDO pathogen
disease MESH Health Services Accessibility

Original Article

(Visited 1 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *